Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs 7,238
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Pipeline programs

Page 118 of 151

  1. SSP-004184AQ

    Takeda

    Iron Overload Due to Repeated Red Blood Cell Transfusions

    phase 2 small molecule terminated

    1 trial

  2. SSS06

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chemotherapy-induced Anemia

    phase 2 small molecule active

    1 trial

  3. SSS17

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Anemia in Pre-Dialysis Patients

    phase 2 small molecule completed

    1 trial

  4. SSS17 Capsule (6 Dose Levels)

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Postoperative Anemia

    phase 2 small molecule active

    1 trial

  5. ST-400 Investigational product

    SANGAMO THERAPEUTICS, INC

    Transfusion Dependent Beta-thalassemia

    phase 2 gene therapy completed

    1 trial

  6. ST-503

    SANGAMO THERAPEUTICS, INC

    Chronic Neuropathic Pain

    phase 2 gene therapy active

    1 trial

  7. ST-920

    SANGAMO THERAPEUTICS, INC

    Fabry Disease (X-linked lysosomal storage disease).

    phase 2 small molecule active

    1 trial

  8. ST-920

    SANGAMO THERAPEUTICS, INC

    Fabry Disease (X-linked lysosomal storage disease).

    phase 2 small molecule active

    1 trial

  9. ST-920

    SANGAMO THERAPEUTICS, INC

    Fabry Disease

    phase 2 mab completed

    1 trial

  10. STAT3 Inhibitor WP1066

    Moleculin Biotech

    Glioblastoma, IDH-Wildtype

    phase 2 small molecule active

    1 trial

  11. STC-15 in combination with toripalimab

    Coherus Oncology

    Solid Tumor

    phase 2 other active

    1 trial

  12. STK-001 - Single Ascending Doses

    Stoke Therapeutics

    Dravet Syndrome

    phase 2 small molecule completed

    1 trial

  13. STML-ELA-0322

    Stemline Therapeutics B.V.

    metastatic breast cancer

    phase 2 small molecule active

    1 trial

  14. STRO-002

    SUTRO BIOPHARMA, INC.

    Neoplasm Malignant

    phase 2 mab completed

    1 trial

  15. STRO-002-GM3

    SUTRO BIOPHARMA, INC.

    Advanced Epithelial Ovarian Cancer (including Fallopian Tube or Primary Peritoneal cancers)

    phase 2 small molecule active

    1 trial

  16. SU2C-001

    BRIGHT MINDS BIOSCIENCES INC.

    Previously Treated Metastatic Pancreatic Cancer

    phase 2 small molecule completed

    1 trial

  17. SV-BR-1-GM

    BriaCell Therapeutics

    Breastcancer

    phase 2 mab completed

    1 trial

  18. SX-682

    United Therapeutics Europe Ltd

    Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

    phase 2 small molecule active

    1 trial

  19. SY-1425, AZACITIDINE

    Lacuna Pharma Pty Ltd

    Acute Myeloid Leukemia (AML) Myelodysplastic Syndrome (MDS)

    phase 2 small molecule active

    1 trial

  20. SY-1425-202

    Lacuna Pharma Pty Ltd

    RARA-positive acute myeloid leukemia

    phase 2 small molecule active

    1 trial

  21. SYR-619

    Takeda

    Diabetes Mellitus

    phase 2 small molecule terminated

    1 trial

  22. SYSUCC-CMY-2022-0416

    The First People's Hospital of Lianyungang

    Nasopharyngeal Carcinoma

    phase 2 small molecule active

    1 trial

  23. Sabin-Based Inactivated Poliomyelitis Vaccine (sIPV)

    Takeda

    Poliomyelitis

    phase 2 mab terminated

    1 trial

  24. Sacituzumab Tirumotecan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Extensive-Stage Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  25. Sacituzumab Tirumotecan and Limertinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    EGFR-mutant Non-small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  26. Sacituzumab Tirumotecan in combination with tislelizumab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 small molecule active

    1 trial

  27. Sacituzumab tirumotecan

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    TNBC - Triple-Negative Breast Cancer

    phase 2 small molecule active

    1 trial

  28. Safety and efficacy of IMM-101 combined with...

    Disc Medicine

    Limited metastatic pancreatic cancer

    phase 2 other active

    1 trial

  29. Sandwich stratergy

    The First People's Hospital of Lianyungang

    Acute Lymphobkastic Leukemia

    phase 2 other active

    1 trial

  30. Sapropterin

    BioMarin Pharmaceutical Australia Pty Ltd

    Phenylketonuria

    phase 2 small molecule terminated

    1 trial

  31. Sapropterin

    BioMarin Pharmaceutical Australia Pty Ltd

    GTP Cyclohydrolase Deficiency

    phase 2 small molecule completed

    1 trial

  32. Sapropterin Dihydrochloride

    BioMarin Pharmaceutical Australia Pty Ltd

    Intermittent Claudication

    phase 2 small molecule completed

    1 trial

  33. Sapropterin Dihydrochloride

    BioMarin Pharmaceutical Australia Pty Ltd

    Endothelial Dysfunction

    phase 2 small molecule completed

    1 trial

  34. Sapropterin Dihydrochloride

    BioMarin Pharmaceutical Australia Pty Ltd

    Sickle Cell Disease

    phase 2 small molecule completed

    1 trial

  35. Sarcosine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Schizophrenias

    phase 2 small molecule completed

    1 trial

  36. Sarcosine and D-serine

    Hospital Authority, Hong Kong

    Schizophrenias

    phase 2 small molecule completed

    1 trial

  37. Sargramostim

    United Therapeutics Europe Ltd

    Covid19

    phase 2 small molecule completed

    1 trial

  38. Sargramostim

    Hospital Authority, Hong Kong

    Pulmonary Alveolar Proteinosis, Autoimmune

    phase 2 small molecule completed

    1 trial

  39. Sargramostim

    Hospital Authority, Hong Kong

    COVID

    phase 2 small molecule completed

    1 trial

  40. Sargramostim

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 small molecule completed

    1 trial

  41. Sarilumab

    Regeneron UK Limited

    Ankylosing Spondylitis

    phase 2 small molecule terminated

    2 trials

  42. Sarilumab

    Regeneron UK Limited

    Morphea, Plaque Form

    phase 2 small molecule terminated

    1 trial

  43. Sarilumab

    Regeneron UK Limited

    Juvenile Idiopathic Arthritis

    phase 2 small molecule completed

    1 trial

  44. Sarilumab SAR153191 (REGN88)

    Regeneron UK Limited

    Juvenile Idiopathic Arthritis

    phase 2 small molecule active

    1 trial

  45. Saruparib

    AstraZeneca AB

    Advanced/Recurrent Ovarian cancer

    phase 2 small molecule active

    1 trial

  46. Sasanlimab Prefilled syringe

    Pfizer

    Carcinoma, Non-Small-Cell Lung

    phase 2 small molecule terminated

    1 trial

  47. Sativex

    Jazz Pharmaceuticals Ireland Limited

    Cancer

    phase 2 small molecule completed

    2 trials

  48. Sativex

    BRIGHT MINDS BIOSCIENCES INC.

    Cannabis Dependence

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.